Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic radiation enteritis. I. Intestinal malabsorption. Anatomo-functional correlates].

J P Gendre, J Cosnes, Y Le Quintrec

    Gastroenterologie Clinique Et Biologique
    |August 1, 1983
    PubMed
    Summary

    Radiation injury to the small intestine causes malabsorption, leading to increased fecal losses. The severity of damage directly correlates with malabsorption in non-operated patients and is influenced by resection extent in operated patients.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab.

    Gut·2017
    Same author

    Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease.

    Alimentary pharmacology & therapeutics·2016
    Same author

    Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn's Disease: A Prospective Cohort-Study in High-Risk Patients.

    Journal of Crohn's & colitis·2016
    Same author

    Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

    Alimentary pharmacology & therapeutics·2015
    Same author

    The outcome of infliximab dose doubling in 157 patients with ulcerative colitis after loss of response to infliximab.

    Alimentary pharmacology & therapeutics·2015
    Same author

    Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease.

    Journal of Crohn's & colitis·2014

    Area of Science:

    • Gastroenterology
    • Radiation Oncology
    • Surgical Gastroenterology